Compare COIN & A Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | COIN | A |
|---|---|---|
| Founded | 2012 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Biotechnology: Laboratory Analytical Instruments |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 48.9B | 39.8B |
| IPO Year | 2021 | 1999 |
| Metric | COIN | A |
|---|---|---|
| Price | $160.67 | $112.12 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 30 | 16 |
| Target Price | ★ $310.33 | $161.06 |
| AVG Volume (30 Days) | ★ 10.3M | 1.9M |
| Earning Date | 05-07-2026 | 02-25-2026 |
| Dividend Yield | N/A | ★ 0.93% |
| EPS Growth | N/A | ★ 3.16 |
| EPS | ★ 4.45 | 1.07 |
| Revenue | ★ $7,181,325,000.00 | $4,472,000,000.00 |
| Revenue This Year | $5.18 | $8.45 |
| Revenue Next Year | $15.17 | $6.10 |
| P/E Ratio | ★ $36.22 | $103.18 |
| Revenue Growth | ★ 9.40 | 6.43 |
| 52 Week Low | $139.36 | $96.43 |
| 52 Week High | $444.65 | $160.27 |
| Indicator | COIN | A |
|---|---|---|
| Relative Strength Index (RSI) | 34.87 | 38.46 |
| Support Level | $152.70 | N/A |
| Resistance Level | $213.49 | $122.96 |
| Average True Range (ATR) | 10.13 | 2.72 |
| MACD | -4.40 | 0.57 |
| Stochastic Oscillator | 4.02 | 34.15 |
Founded in 2012, Coinbase is the leading cryptocurrency exchange platform in the United States. The company intends to be the safe and regulation-compliant point of entry for retail investors and institutions into the cryptocurrency economy. Users can establish an account directly with the firm, instead of using an intermediary, and many choose to allow Coinbase to act as a custodian for their cryptocurrency, giving the company breadth beyond that of a traditional financial exchange. While the company still generates the majority of its revenue from transaction fees charged to its retail customers, Coinbase uses internal investment and acquisitions to expand into adjacent businesses, such as prime brokerage and data analytics.
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools, cross lab consisting of consumables and services related to life science and applied tools, and diagnostics and genomics. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest country concentrations.